Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Sujung | - |
dc.contributor.author | Kim, Jieun E. | - |
dc.contributor.author | Hwang, Jaeuk | - |
dc.contributor.author | Kim, Tae-Suk | - |
dc.contributor.author | Kang, Hee Jin | - |
dc.contributor.author | Namgung, Eun | - |
dc.contributor.author | Ban, Soonhyun | - |
dc.contributor.author | Oh, Subin | - |
dc.contributor.author | Yang, Jeongwon | - |
dc.contributor.author | Renshaw, Perry F. | - |
dc.contributor.author | Lyoo, In Kyoon | - |
dc.date.accessioned | 2021-08-11T16:46:50Z | - |
dc.date.available | 2021-08-11T16:46:50Z | - |
dc.date.issued | 2016-09-15 | - |
dc.identifier.issn | 0006-3223 | - |
dc.identifier.issn | 1873-2402 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8760 | - |
dc.description.abstract | BACKGROUND: Creatine monohydrate (creatine) augmentation has the potential to accelerate the clinical responses to and enhance the overall efficacy of selective serotonin reuptake inhibitor treatment in women with major depressive disorder (MDD). Although it has been suggested that creatine augmentation may involve the restoration of brain energy metabolism, the mechanisms underlying its antidepressant efficacy are unknown. METHODS: In a randomized, double-blind, placebo-controlled trial, 52 women with MDD were assigned to receive either creatine augmentation or placebo augmentation of escitalopram; 34 subjects participated in multimodal neuroimaging assessments at baseline and week 8. Age-matched healthy women (n = 39) were also assessed twice at the same intervals. Metabolic and network outcomes were measured for changes in prefrontal N-acetylaspartate and changes in rich club hub connections of the structural brain network using proton magnetic resonance spectroscopy and diffusion tensor imaging, respectively. RESULTS: We found MDD-related metabolic and network dysfunction at baseline. Improvement in depressive symptoms was greater in patients receiving creatine augmentation relative to placebo augmentation. After 8 weeks of treatment, prefrontal N-acetylaspartate levels increased significantly in the creatine augmentation group compared with the placebo augmentation group. Increment in rich club hub connections was also greater in the creatine augmentation group than in the placebo augmentation group. CONCLUSIONS: N-acetylaspartate levels and rich club connections increased after creatine augmentation of selective serotonin reuptake inhibitor treatment. Effects of creatine administration on brain energy metabolism and network organization may partly underlie its efficacy in treating women with MDD. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.biopsych.2015.11.027 | - |
dc.identifier.scopusid | 2-s2.0-84955587099 | - |
dc.identifier.wosid | 000382260500010 | - |
dc.identifier.bibliographicCitation | Biological Psychiatry, v.80, no.6, pp 439 - 447 | - |
dc.citation.title | Biological Psychiatry | - |
dc.citation.volume | 80 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 439 | - |
dc.citation.endPage | 447 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | RICH-CLUB ORGANIZATION | - |
dc.subject.keywordPlus | MAGNETIC-RESONANCE-SPECTROSCOPY | - |
dc.subject.keywordPlus | STRUCTURAL NETWORKS | - |
dc.subject.keywordPlus | SEX-DIFFERENCES | - |
dc.subject.keywordPlus | SEROTONIN | - |
dc.subject.keywordPlus | CORTEX | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | BIOENERGETICS | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | CITALOPRAM | - |
dc.subject.keywordAuthor | Antidepressant | - |
dc.subject.keywordAuthor | Brain bioenergetics | - |
dc.subject.keywordAuthor | Creatine monohydrate | - |
dc.subject.keywordAuthor | Major depressive disorder | - |
dc.subject.keywordAuthor | Network organization | - |
dc.subject.keywordAuthor | Selective serotonin reuptake inhibitor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.